Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DOLORisk: Understanding Risk Factors and Determinants for Neuropathic Pain - Peripheral Physiological Measures as Determinants of Pain Risk

NCT02985294 is registered in ClinicalTrials.gov with Neuroscience Technologies SLP, Barcelona as lead sponsor.

NCT NCT02985294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02985294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DOLORisk: Understanding Risk Factors and Determinants for Neuropathic Pain - Peripheral Physiological Measures as Determinants of Pain Risk
Lead sponsor
Neuroscience Technologies SLP, Barcelona
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2016
Completion date
April 30, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effects, neuralgia, peripheral nerve injuries, peripheral nervous system diseases, polyneuropathies